114 related articles for article (PubMed ID: 1578480)
21. Beta-lactam analogues of oxotremorine. 3- and 4-methyl-substituted 2-azetidinones.
Nilsson BM; Ringdahl B; Hacksell U
J Med Chem; 1990 Feb; 33(2):580-4. PubMed ID: 2299626
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneity of muscarinic autoreceptors and heteroreceptors in the rat brain: effects of a novel M1 agonist, AF102B.
Ono S; Saito Y; Ohgane N; Kawanishi G; Mizobe F
Eur J Pharmacol; 1988 Oct; 155(1-2):77-84. PubMed ID: 3243333
[TBL] [Abstract][Full Text] [Related]
23. Urea and 2-imidazolidone derivatives of the muscarinic agents oxotremorine and N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
Nilsson BM; Vargas HM; Hacksell U
J Med Chem; 1992 Aug; 35(17):3270-9. PubMed ID: 1507212
[TBL] [Abstract][Full Text] [Related]
24. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
25. Direct autoradiographic determination of M1 and M2 muscarinic acetylcholine receptor distribution in the rat brain: relation to cholinergic nuclei and projections.
Spencer DG; Horváth E; Traber J
Brain Res; 1986 Aug; 380(1):59-68. PubMed ID: 3756473
[TBL] [Abstract][Full Text] [Related]
26. New analogues of oxotremorine and oxotremorine-M: estimation of their in vitro affinity and efficacy at muscarinic receptor subtypes.
Barocelli E; Ballabeni V; Bertoni S; Dallanoce C; De Amici M; De Micheli C; Impicciatore M
Life Sci; 2000 Jun; 67(6):717-23. PubMed ID: 12659177
[TBL] [Abstract][Full Text] [Related]
27. Oxotremorine-m potentiation of glucose-induced insulin release from rat islets involves M3 muscarinic receptors.
Boschero AC; Szpak-Glasman M; Carneiro EM; Bordin S; Paul I; Rojas E; Atwater I
Am J Physiol; 1995 Feb; 268(2 Pt 1):E336-42. PubMed ID: 7864111
[TBL] [Abstract][Full Text] [Related]
28. Selectivity of partial agonists related to oxotremorine based on differences in muscarinic receptor reserve between the guinea pig ileum and urinary bladder.
Ringdahl B
Mol Pharmacol; 1987 Apr; 31(4):351-6. PubMed ID: 3574286
[TBL] [Abstract][Full Text] [Related]
29. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes.
Arnt J; Lembøl HL; Meier E; Pedersen H
Eur J Pharmacol; 1992 Jul; 218(1):159-69. PubMed ID: 1397027
[TBL] [Abstract][Full Text] [Related]
30. Muscarinic receptors mediating inhibition of gamma-aminobutyric acid release in rat corpus striatum and their pharmacological characterization.
Raiteri M; Marchi M; Paudice P; Pittaluga A
J Pharmacol Exp Ther; 1990 Aug; 254(2):496-501. PubMed ID: 2384883
[TBL] [Abstract][Full Text] [Related]
31. Muscarinic M1, M2 receptor binding. Relationship with functional efficacy.
Freedman SB; Beer MS; Harley EA
Eur J Pharmacol; 1988 Oct; 156(1):133-42. PubMed ID: 3208836
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro pharmacology of novel heterocyclic muscarinic ligands.
De Amici M; Conti P; Fasoli E; Barocelli E; Ballabeni V; Bertoni S; Impicciatore M; Roth BL; Ernsberger P; De Micheli C
Farmaco; 2003 Sep; 58(9):739-48. PubMed ID: 13679167
[TBL] [Abstract][Full Text] [Related]
33. [3H]AF-DX 116 labels subsets of muscarinic cholinergic receptors in rat brain and heart.
Wang JX; Roeske WR; Gulya K; Wang W; Yamamura HI
Life Sci; 1987 Oct; 41(14):1751-60. PubMed ID: 3657382
[TBL] [Abstract][Full Text] [Related]
34. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
Lee W; Wolfe BB
Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and action of oxotremorine-related hybrid-type allosteric modulators of muscarinic acetylcholine receptors.
Disingrini T; Muth M; Dallanoce C; Barocelli E; Bertoni S; Kellershohn K; Mohr K; De Amici M; Holzgrabe U
J Med Chem; 2006 Jan; 49(1):366-72. PubMed ID: 16392821
[TBL] [Abstract][Full Text] [Related]
36. Antimuscarinic potency and functional selectivity of oxotremorine analogs at muscarinic receptor subtypes in the rat.
Vargas HM; Ringdahl B
Life Sci; 1990; 47(22):2065-73. PubMed ID: 1703260
[TBL] [Abstract][Full Text] [Related]
37. Agonist binding to M1 muscarinic receptors is sensitive to guanine nucleotides.
Flynn DD; Palermo N; Suarez A
Eur J Pharmacol; 1989 Oct; 172(4-5):363-72. PubMed ID: 2583247
[TBL] [Abstract][Full Text] [Related]
38. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
39. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
40. Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes.
Lambrecht G; Feifel R; Wagner-Röder M; Strohmann C; Zilch H; Tacke R; Waelbroeck M; Christophe J; Boddeke H; Mutschler E
Eur J Pharmacol; 1989 Sep; 168(1):71-80. PubMed ID: 2583233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
